Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Q3 2023 13F Holders as of 9/30/2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Number of holders: 57
Total Shares: 36.6M
Shares change: +341K
Total reported value, excl. options: $113M
Value change: +$1.04M
Put/Call ratio: 6
Number of buys: 30
Number of sells: -17
Price: $3.09

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.